Skip to main content

Allergic Ocular Diseases

  • Living reference work entry
  • First Online:
  • 228 Accesses

Abstract

The ocular surface may exhibit a wide variety of immunologic responses resulting in inflammation of the conjunctiva and cornea. Diagnosis of allergic conjunctivitis is generally made by thorough history and careful clinical observation. The presence of an antigen triggers the allergic cascade, and, thus, avoidance of the offending antigen is the primary behavioral modification for all types of allergic conjunctivitis (Takamura et al., Allergol Int 66:220–229, 2017; Takamura, J Jpn Ophthalmol Soc 114:831–870, 2010). In the diagnosis of allergic conjunctival diseases, it is required that type I allergic diathesis is present, along with subjective symptoms and objective findings accompanying allergic inflammation (Singh et al., J Allergy Clin Immunol 126:778–783, 2010).

This is a preview of subscription content, log in via an institution.

References

  • Abelson MB, Shetty S, Korchak M, Butrus SI, Smith LM. Advances in pharmacotherapy for allergic conjunctivitis. Expert Opin Pharmacother. 2015;16:1219–31.

    Article  CAS  PubMed Central  Google Scholar 

  • Allansmith MR, Korb DR, Greiner JV, Henriquez AS, Simon MA, Finnemore VM. Giant papillary conjunctivitis in contact lens wearers. Am J Ophthalmol. 1977;83:697–708.

    Article  CAS  PubMed Central  Google Scholar 

  • Aswad MI, Tauber J, Baum J. Plasmapheresis treatment in patients with severe atopic keratoconjunctivitis. Ophthalmology. 1988;954:444–7.

    Article  Google Scholar 

  • Bielory BP, O'Brien TP, Bielory L. Management of seasonal allergic conjunctivitis: guide to therapy. Acta Ophthalmol. 2012;90:399–407.

    Article  CAS  PubMed Central  Google Scholar 

  • Chen JJ, Applebaum DS, Sun GS, Pflugfelder SC. Atopic keratoconjunctivitis: a review. J Am Acad Dermatol. 2014;703:569–75.

    Article  Google Scholar 

  • Ebert FP. National Research Council (US) working group on contact Lens use under adverse conditions. Washington, DC: National Academies Press; 1990.

    Google Scholar 

  • Finn DF, Walsh JJ. Twenty-first century mast cell stabilizers. Br J Pharmacol. 2013;170:23–37.

    Article  CAS  PubMed Central  Google Scholar 

  • Friedlaender MH. Contact allergy and toxicity in the eye. Int Ophthalmol Clin. 1998;28:317–20.

    Article  Google Scholar 

  • Gonzalez-Estrada A, Reddy K, Dimov V, Eidelman F. Olopatadine hydrochloride ophthalmic solution for the treatment of allergic conjunctivitis. Expert Opin Pharmacother. 2017;18:1137–43.

    Article  CAS  PubMed Central  Google Scholar 

  • Henriquez AS, Kenyon KR, Allansmith MR. Mast cell ultrastructure: comparison in contact lens-associated giant papillary conjunctivitis and vernal conjunctivitis. Arch Ophthalmol. 1981;99:1266–72.

    Article  CAS  PubMed Central  Google Scholar 

  • Hogan MJ. Atopic keratoconjunctivitis. Am J Ophthalmol. 1953;36:937–47.

    Article  CAS  PubMed Central  Google Scholar 

  • Kashima T, Itakura H, Akiyama H, Kishi S. Rebamipide ophthalmic suspension for the treatment of dry eye syndrome: a critical appraisal. Clin Ophthalmol. 2014;30:1003–10.

    Article  Google Scholar 

  • Kumar S. Vernal keratoconjunctivitis: a major review. Acta Ophthalmol. 2009;872:133–47.

    Article  Google Scholar 

  • Molinari JF. Giant papillary conjunctivitis management in hydrogel contact lens wearers. J Br Contact Lens Assoc. 1982;5:94–9.

    Article  Google Scholar 

  • Niederkorn JY. Immune regulatory mechanisms in allergic conjunctivitis: insights from mouse models. Curr Opin Allergy Clin Immunol. 2008;8:472–6.

    Article  PubMed Central  Google Scholar 

  • Ohashi Y, Ebihara N, Fujishima H, Fukushima A, Kumagai N, Nakagawa Y. A randomized, placebo-controlled clinical trial of tacrolimus ophthalmic suspension 0.1% in severe allergic conjunctivitis. J Ocul Pharmacol Ther. 2010;26:165–74.

    Article  CAS  PubMed Central  Google Scholar 

  • Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988–1994. J Allergy Clin Immunol. 2010;126:778–83.

    Article  PubMed Central  Google Scholar 

  • Takamura E. Japanese Ocular Allergology society. Guidelines for the clinical management of allergic conjunctival disease (2nd edition). J Jpn Ophthalmol Soc. 2010;114:831–70.

    Google Scholar 

  • Takamura E, Uchio E, Ebihara N, Ohno S, Ohashi Y, Okamoto S, Kumagai N, Satake Y, Shoji J, Nakagawa Y, Namba K, Fukagawa K, Fukushima A, Fujishima H. Japanese Society of Allergology. Japanese guidelines for allergic conjunctival diseases 2017. Allergol Int. 2017;66:220–9.

    Article  PubMed Central  Google Scholar 

  • Wahn U, Klimek L, Ploszczuk A, Adelt T, Sandner B, Trebas-Pietras E. High-dose sublingual immunotherapy with single-dose aqueous grass pollen extract in children is effective and safe: a double-blind, placebo-controlled study. J Allergy Clin Immunol. 2012;130:886–93. e5

    Article  CAS  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Satoshi Yoshida .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Yoshida, S. (2018). Allergic Ocular Diseases. In: Craig, T., Ledford, D. (eds) Allergy and Asthma. Springer, Cham. https://doi.org/10.1007/978-3-319-58726-4_4-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-58726-4_4-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-58726-4

  • Online ISBN: 978-3-319-58726-4

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics